Jack Nathan Medical Corp.
JNHMF · OTC
7/31/2025 | 4/30/2025 | 1/31/2025 | 10/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$0 | -$0 | $0 | $0 |
| Revenue | $0 | $0 | -$0 | $0 |
| % Growth | -88.6% | 149.6% | -176.5% | – |
| Gross Profit | -$0 | $0 | -$0 | $0 |
| % Margin | -3.8% | 82.9% | 72.5% | 81.7% |
| EBITDA | -$0 | -$0 | $0 | -$0 |
| % Margin | -202.2% | -40% | -32.2% | -19.5% |
| Net Income | -$0 | -$0 | $0 | -$0 |
| % Margin | -18.5% | -49.4% | -303.8% | -34.2% |
| EPS Diluted | -0.003 | -0.011 | 0.024 | -0.021 |
| % Growth | 74.3% | -146.5% | 218% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |